Junhong Li
Overview
Explore the profile of Junhong Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
226
Citations
2106
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shi C, Liu F, Su X, Yang Z, Wang Y, Xie S, et al.
Cell Res
. 2025 Mar;
35(3):229.
PMID: 40065135
No abstract available.
2.
Li X, Chang Y, Zhao X, Liu X, Zhang Y, Wang X, et al.
Front Public Health
. 2025 Mar;
13:1513526.
PMID: 40061466
Objective: To assess health inequities associated with retinoblastoma across various Socio-Demographic Index (SDI) regions and evaluate whether these inequities have decreased from 1990 to 2021, with the aim of enhancing...
3.
Li J, Zhang M, Sun Q, Li X, Du F, Cheng Y, et al.
Cancer Cell Int
. 2025 Mar;
25(1):73.
PMID: 40025532
Background: Glioma is the most common primary malignant tumor of the central nervous system, and due to the limited effectiveness of traditional single-target therapies, there is an urgent need for...
4.
Zhai Y, Ji C, Wang Y, Qu C, He C, Lu F, et al.
Biomed Opt Express
. 2025 Feb;
16(2):535-552.
PMID: 39958844
Phacoemulsification with intraocular lens (IOL) implantation is a widely used effective treatment for cataracts. However, the surgical outcome relies heavily on precise operations with marked eye location and orientation, which...
5.
Li J, Lv W, Han Z, Li Y, Deng J, Huang Y, et al.
Adv Sci (Weinh)
. 2025 Feb;
:e2501542.
PMID: 39950857
Chemo-immunotherapy, combining systemic chemotherapeutic drugs and immune checkpoint blockers, is a promising paradigm in cancer treatment. However, challenges such as limited induction of immune responses and systemic immune toxicity have...
6.
Pang W, Song Y, Xie J, Yan X, Luo Y, Qiu K, et al.
Scand J Work Environ Health
. 2025 Feb;
51(2):77-88.
PMID: 39946747
Objectives: This study aimed to investigate the association between working behaviors and sensorineural hearing loss (SNHL). Methods: A cross-sectional analysis was conducted (N=90 286) to assess the association between working...
7.
Li J, Wang F, Liu J, Bashir S, Ma S, Cao M, et al.
ACS Nano
. 2025 Feb;
19(7):6942-6954.
PMID: 39937183
The impacts of zinc oxide nanoparticles (ZnO NPs) as nanofertilizers on the transformation of phytogenic organic phosphorus (OP), specifically phytic acid (PA) and soy lecithin (LE), as well as their...
8.
Xiao E, Yu R, Cai X, Jiang L, Li J, Ma C, et al.
Lipids Health Dis
. 2025 Feb;
24(1):45.
PMID: 39934775
Objective: The prevalence of prediabetes among adults in the U.S. is three times higher than that of diabetes, highlighting a greater disease burden. Both diabetes and prediabetes have been demonstrated...
9.
Wang X, Pang W, Hu X, Shu T, Luo Y, Li J, et al.
Hum Genet
. 2025 Jan;
PMID: 39841246
The genetic relationship between migraine and stroke remains underexplored, particularly in the context of druggable targets. Previous studies have been limited by small sample sizes and a lack of focus...
10.
Yue K, Xu S, Hu X, Li J, He R, Jiang Z
Front Neurol
. 2025 Jan;
15():1513867.
PMID: 39839867
Introduction: Conventional management approaches have been challenged in dealing with zoster-related trigeminal neuralgia. Percutaneous trigeminal ganglion stimulation (TGS) has been rarely reported as a potential treatment option for alleviating pain...